medline.ch Urologie-Nephrologie

	Aldosterone excess, blood pressure control, and kidney outcomes in chronic kidney disease: findings from the Cardiovascular and Metabolic Disease Etiology Research Center-High Risk (CMERC-HI) Study. Hypertens Res Jhee JH, Joo YS, Seo J, Lee CJ, Ko YE, Park SH, Yoo TH, Park S. PMID: 42304125 [PubMed - as supplied by publisher]
	Navigating work after prostate cancer treatment: a systematic review of qualitative research. J Cancer Surviv Tomic D, Keegel T, Schellack SK, Abdel-Malek L, Jander C, Hettige ST, MacFarlane E, Millar J, Walker-Bone K. PMID: 42303926 [PubMed - as supplied by publisher]
	Single-port robotic non-transecting Y-V flap pyeloplasty with stricturoplasty for ureteropelvic junction obstruction: a case series. World J Urol Ratanapornsompong W, Sarawong S, Walasek A, Lin JS, Elbakry A, Zhao LC. PMID: 42303909 [PubMed - indexed for MEDLINE]
	Urological telesurgery after the first randomised trial: a scoping review and public implementation visibility audit. J Robot Surg Drobot RB, Skorupka JJ, Antoniewicz AA. PMID: 42303805 [PubMed - indexed for MEDLINE]
	Comparative study on the protective effects of Silybum marianum L. seeds and leaves against nickel chloride induced anemia, liver and kidney injury: an in vivo and in silico approach. Sci Rep Iraqi O, Jalal M, Lamtai M, Merzouki O, Nouayti A, El Brouzi MY, Nouayti H, Noman O, Shahat AA, Dimaoui A, Nouayti R, Channaoui S, Basilua JM, Taboz Y, Habsaoui A. PMID: 42303676 [PubMed - as supplied by publisher]
	A preoperative Artificial Intelligence model to estimate cancer-specific mortality in nonmetastatic kidney cancer patients. Nat Commun Larcher A, Traverso A, Scuri P, Capitanio U, Musso G, Canibus D, Barbieri S, Caivano L, Zambello A, Denti M, Campi R, Serni S, Granata S, Palmisano A, Vignale D, Montorsi F, Esposito A, Tacchetti C, Salonia A. PMID: 42303642 [PubMed - as supplied by publisher]
	Racial and Ethnic Disparities in Cytomegalovirus Disease Progression Among Kidney Transplant Recipients: A Single-Center Exploratory Study. Transplant Proc Cabanilla MG, Dauenhauer A, St John B. PMID: 42303542 [PubMed - as supplied by publisher]
	Overall Survival of Patients With PSA-Recurrent Prostate Cancer: Long-Term Analysis of a Randomized Phase 2 Trial of pTVG-HP DNA Vaccine Versus Placebo. Clin Genitourin Cancer McNeel DG, Eickhoff JC, Perez A, Liu G. PMID: 42303538 [PubMed - as supplied by publisher]
	Re: Final Overall Survival Results from EORTC 1333/PEACE-3 Trial of Enzalutamide plus Radium-223 in Metastatic Castration-resistant Prostate Cancer. Eur Urol Francini E. PMID: 42303526 [PubMed - as supplied by publisher]
	Re: Safety and Efficacy of Tranexamic Acid in Urologic Surgery: Results from the International, Randomized, Placebo-Controlled POISE-3 Trial. Eur Urol Chen L, Lu W. PMID: 42303525 [PubMed - as supplied by publisher]
	Re: Neoadjuvant Sacituzumab Govitecan plus Pembrolizumab, Followed by Adjuvant Pembrolizumab, in Patients with Muscle-invasive Bladder Cancer (SURE-02): A Single-arm, Phase 2 Study. Eur Urol Mertens LS, Mellema JJ, Sridhar S, van der Heijden MS. PMID: 42303524 [PubMed - as supplied by publisher]
	Re: Pembrolizumab in Combination with Gemcitabine and Concurrent Hypofractionated Radiation Therapy as Bladder-sparing Treatment for Muscle-invasive Urothelial Cancer of the Bladder: A Multicenter Phase 2 Trial. Eur Urol Ma H, Zhou Q. PMID: 42303523 [PubMed - as supplied by publisher]
	Re: Stereotactic Body Radiation Therapy for Oligoprogressive Disease in Androgen-suppressed Prostate Cancer: Primary Endpoint Analysis of the TRAP Trial. Eur Urol Yusuf S, Azam A, Sood I, Al-Sattar H, Mullassery V, Adeleke S. PMID: 42303522 [PubMed - as supplied by publisher]
	Re: Aboubacar Kaba, Pratik Kanabur, Jeremie Calais, et al. Performance of [89 Zr]girentuximab PET/CT in Predicting the Presence of Any Renal Malignancy: A Reanalysis of the ZIRCON Trial. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2026.03.003. Eur Urol Ghoreifi A, Daneshvar M. PMID: 42303521 [PubMed - as supplied by publisher]
	Concomitant MRI-detected and MRI-undetected Prostate Cancer with Implications for Biopsy Strategies and Focal Therapy Planning: An Analysis of the PROMIS and PICTURE Trials. Eur Urol Oncol Light A, Peters M, Gopalakrishnan A, Mayor N, Freeman A, Emberton M, Ahmed HU, Shah TT. PMID: 42303478 [PubMed - as supplied by publisher]
	Clinical Implications of Glomerulation After Cystoscopic Hydrodistention in Patients With Interstitial Cystitis and Bladder Pain Syndrome. Int J Urol Yu WR, Jiang YH, Jhang JF, Kuo HC. PMID: 42303446 [PubMed - indexed for MEDLINE]
	Angiogenesis, Angiogenic Factors, and Interstitial Cystitis/Bladder Pain Syndrome (IC/BPS). Int J Urol Yoshimura N, Furuta A, Tobisawa Y, Igarashi T, Saito T, Ueda T. PMID: 42303427 [PubMed - indexed for MEDLINE]
	Definition and Clinical Symptoms of Interstitial Cystitis/Bladder Pain Syndrome. Int J Urol Taneja R. PMID: 42303419 [PubMed - indexed for MEDLINE]
	Serum and Urine Biomarkers for Interstitial Cystitis/Bladder Pain Syndrome. Int J Urol Torimoto K, Ueda T. PMID: 42303411 [PubMed - indexed for MEDLINE]
	Low-Energy Shockwave Therapy for Interstitial Cystitis/Bladder Pain Syndrome From Bench to Clinic. Int J Urol Tsai CH, Shen YC, Wang HJ, Lee WC, Kao CY, Chuang YC. PMID: 42303410 [PubMed - indexed for MEDLINE]

Artikel 1 - 20 / 474325

Seite 1 von 23717

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung